Christophe Hezode, MD, of the Hôpital Henri Mondor, Creteil, France, et al. stated the following on Oct. 31, 2004 at the 55th Annual Meeting of the American Association for the Study of Liver Diseases, in describing his study of Hepatitis C patients who also used cannabis [marijuana]:

“This study shows a strong link between daily cannabis consumption and fibrosis [scarring of the liver] progression rate in patients with chronic hepatitis C…

Daily cannabis consumption should be avoided in patients with chronic hepatitis C. Patients with HCV infection who smoke cannabis to help with fatigue or appetite should really be aware that daily consumption could exacerbate their disease.”

Oct. 31, 2004